tiprankstipranks

Teladoc price target lowered to $8 from $12 at DA Davidson

DA Davidson lowered the firm’s price target on Teladoc to $8 from $12 and keeps a Neutral rating on the shares. The firm cites the company withdrawing its top- and bottom-line guidance for 2024, as well as its three-year financial targets, in response to acute uncertainty in its Betterhelp business, though the Integrated Care segment continues to be Teladoc’s greatest strength, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue